Anti-KIAA0556 monoclonal antibody

Pre-made anti-KIAA0556 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KIAA0556/KIAA0556 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2556-Ab-1/ GM-Tg-hg-IP2556-Ab-2Anti-Human KIAA0556 monoclonal antibodyHuman
GM-Tg-rg-IP2556-Ab-1/ GM-Tg-rg-IP2556-Ab-2Anti-Rat KIAA0556 monoclonal antibodyRat
GM-Tg-mg-IP2556-Ab-1/ GM-Tg-mg-IP2556-Ab-2Anti-Mouse KIAA0556 monoclonal antibodyMouse
GM-Tg-cynog-IP2556-Ab-1/ GM-Tg-cynog-IP2556-Ab-2Anti-Cynomolgus/ Rhesus macaque KIAA0556 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2556-Ab-1/ GM-Tg-felg-IP2556-Ab-2Anti-Feline KIAA0556 monoclonal antibodyFeline
GM-Tg-cang-IP2556-Ab-1/ GM-Tg-cang-IP2556-Ab-2Anti-Canine KIAA0556 monoclonal antibodyCanine
GM-Tg-bovg-IP2556-Ab-1/ GM-Tg-bovg-IP2556-Ab-2Anti-Bovine KIAA0556 monoclonal antibodyBovine
GM-Tg-equg-IP2556-Ab-1/ GM-Tg-equg-IP2556-Ab-2Anti-Equine KIAA0556 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2556-Ab-1/ GM-Tg-hg-IP2556-Ab-2; GM-Tg-rg-IP2556-Ab-1/ GM-Tg-rg-IP2556-Ab-2;
GM-Tg-mg-IP2556-Ab-1/ GM-Tg-mg-IP2556-Ab-2; GM-Tg-cynog-IP2556-Ab-1/ GM-Tg-cynog-IP2556-Ab-2;
GM-Tg-felg-IP2556-Ab-1/ GM-Tg-felg-IP2556-Ab-2; GM-Tg-cang-IP2556-Ab-1/ GM-Tg-cang-IP2556-Ab-2;
GM-Tg-bovg-IP2556-Ab-1/ GM-Tg-bovg-IP2556-Ab-2; GM-Tg-equg-IP2556-Ab-1/ GM-Tg-equg-IP2556-Ab-2
Products NameAnti-KIAA0556 monoclonal antibody
Formatmab
Target NameKIAA0556
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KIAA0556 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2556-Ag-1Recombinant multi-species KATIP/ KIAA0556/ JBTS26 protein


    Target information

    Target IDGM-IP2556
    Target NameKIAA0556
    Gene ID23247,233865,361646,706125,479799,101095302,520970,100066772
    Gene Symbol and SynonymsD430042O09Rik,JBTS26,KATNIP,KIAA0556,RGD1307324
    Uniprot AccessionO60303
    Uniprot Entry NameKATIP_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000047578
    Target ClassificationN/A

    The target: KIAA0556, gene name: KIAA0556, also named as JBTS26. This gene encodes a novel, evolutionarily conserved, ciliary protein. In human hTERT-RPE1 cells, the protein is found at the base of cilia, decorating the ciliary axoneme, and enriched at the ciliary tip. The protein binds to microtubules in vitro and regulates their stability when it is overexpressed. A null mutation in this gene has been associated with Joubert syndrome, a recessive disorder that is characterized by a distinctive mid-hindbrain and cerebellar malformation and is also often associated with wider ciliopathy symptoms. Consistently, in a serum-starvation ciliogenesis assay, human fibroblast cells derived from patients with the mutation display a reduced number of ciliated cells with abnormally long cilia. [provided by RefSeq, Feb 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.